Browsing Category
Health-Lifestyle
Covid vax doesn’t raise risk of rare neurological events: Study
London, March 17 (IANS) There is no increased risk of rare neurological events after Covid-19 vaccination, revealed a study of more than eight million people.
There were several reports indicating an increased risk of Bell's palsy (facial!-->…
Read More...
Read More...
Exercise key to keep muscles healthy, stay young
London, March 17 (IANS) Want to stay young? Lifelong physical activity could protect against age-related loss of muscle mass and function, according to research.
The study, published in The Journal of Physiology, showed that individuals!-->…
Read More...
Read More...
Massive acceleration needed to fill sanctioned nursing positions in India
New Delhi, March 17 (IANS) Nurses and midwives form the cornerstone of healthcare delivery in India and are the unflinching pillars on which our healthcare system rests. The WHO Global Strategic Directions for Nursing and Midwifery!-->…
Read More...
Read More...
WHO delays assessment of Russia’s Sputnik Covid vax
Geneva, March 17 (IANS) The World Health Organization (WHO) has delayed the assessment process for granting emergency use authorisation to Russia's Sputnik V vaccine against Covid, in the wake of its invasion of Ukraine.
According to a WHO!-->…
Read More...
Read More...
Climate change may cause longer, more intense allergy seasons
New York, March 17 (IANS) Increasing temperatures caused by human made climate change and rise in carbon dioxide levels are likely to drive trees, grasses, weeds to produce more pollen, resulting in longer and more intense allergy seasons,!-->…
Read More...
Read More...
‘Jan Aushadhi medicine led to estimated savings of Rs 4,800 cr for people’
New Delhi, March 17 (IANS) Jan Aushadhi medicines are 50-90 per cent cheaper over market prices of branded medicines, and during the current financial year till February 28, 2022, have led to estimated savings of approximately Rs 4,800!-->…
Read More...
Read More...
Corbevax vax to cost Rs 990 in market, Rs 145 for govt
New Delhi, March 16 (IANS) Biological E produced Corbevax vaccine shot for children between 12 to 14 age group will cost Rs 990 in the private market including all taxes and Rs 145 at government hospitals and facilities.
India on Wednesday!-->…
Read More...
Read More...
With 2025 in sight, govt to launch door-to-door TB screening on ‘war footing’
<br>The initiative will be launched officially on March 24, globally observed as World TB Day.
Under this initiative, over the next two to three weeks, health workers will be visiting the vulnerable population that is potentially!-->…
Read More...
Read More...